1 Bray, F. et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin68 394 (2018).
2 Chen, W. et al., Cancer incidence and mortality in China, 2014. Chin J Cancer Res30 1 (2018).
3 Adam, R., Colorectal cancer with synchronous liver metastases. BRIT J SURG94 129 (2007).
4 Rees, M., Tekkis, P. P., Welsh, F. K. S., OʼRourke, T. & John, T. G., Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer. ANN SURG247 125 (2008).
5 Favoriti, P. et al., Worldwide burden of colorectal cancer: a review. Updates in Surgery68 7 (2016).
6 McMillan, D. C. & McArdle, C. S., Epidemiology of colorectal liver metastases. Surgical Oncology16 3 (2007).
7 Manfredi, S. et al., Epidemiology and Management of Liver Metastases From Colorectal Cancer. ANN SURG244 254 (2006).
8 Trepo, C., Chan, H. L. & Lok, A., Hepatitis B virus infection. LANCET384 2053 (2014).
9 Tanaka, M. et al., Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures. J EPIDEMIOL21 401 (2011).
10 Luo, Z., Li, L. & Ruan, B., Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. INT J INFECT DIS16 e82 (2012).
11 Bréchot, C., Gozuacik, D., Murakami, Y. & Paterlini-Bréchot, P., Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). SEMIN CANCER BIOL10 211 (2000).
12 Chuang, S., Vecchia, C. L. & Boffetta, P., Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection. CANCER LETT286 9 (2009).
13 Levrero, M. & Zucman-Rossi, J., Mechanisms of HBV-induced hepatocellular carcinoma. J HEPATOL64 S84 (2016).
14 Luo, G. et al., HBV infection increases the risk of pancreatic cancer: a meta-analysis. CANCER CAUSE CONTROL24 529 (2013).
15 Wei, X. L. et al., The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer. J TRANSL MED11 249 (2013).
16 Zhou, X. et al., Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma. BMC CANCER19 (2019).
17 Utsunomiya, T. et al., Rare occurrence of colorectal cancer metastasis in livers infected with Hepatitis B or C virus. The American Journal of Surgery177 279 (1999).
18 Song, E., Chen, J., Ou, Q. & Su, F., Rare occurrence of metastatic colorectal cancers in livers with replicative hepatitis B infection. AM J SURG181 529 (2001).
19 Augustin, G., Bruketa, T., Korolija, D. & Milosevic, M., Lower incidence of hepatic metastases of colorectal cancer in patients with chronic liver diseases: meta-analysis. Hepatogastroenterology60 1164 (2013).
20 Cai, B. et al., Patients with chronically diseased livers have lower incidence of colorectal liver metastases: a meta-analysis. PLOS ONE9 e108618 (2014).
21 Zhao, Y. et al., Hepatitis B Virus Infection Predicts Better Survival In Patients With Colorectal Liver-only Metastases Undergoing Liver Resection. J CANCER9 1560 (2018).
22 Huo, T. et al., Effect of Concomitant Positive Hepatitis B Surface Antigen on the Risk of Liver Metastasis: A Retrospective Clinical Study of 4033 Consecutive Cases of Newly Diagnosed Colorectal Cancer. CLIN INFECT DIS66 1948 (2018).
23 Kow, A. W. C., Hepatic metastasis from colorectal cancer. Journal of Gastrointestinal Oncology10 1274 (2019).
24 Qiu, H., HBV infection decreases risk of liver metastasis in patients with colorectal cancer: A cohort study. WORLD J GASTROENTERO17 804 (2011).
25 Li, D. G. et al., Rare hepatic metastases of colorectal cancer in livers with symptomatic HBV and HCV hepatitis. ANN ITAL CHIR84 323 (2013).
26 Wang, F. S., Shao, Z. G., Zhang, J. L. & Liu, Y. F., Colorectal liver metastases rarely occur in patients with chronic hepatitis virus infection. Hepatogastroenterology59 1390 (2012).
27 Kelly, R. J., Kemeny, N. E. & Leonard, G. D., Current strategies using hepatic arterial infusion chemotherapy for the treatment of colorectal cancer. Clin Colorectal Cancer5 166 (2005).
28 Pancione, M. et al., Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis. J IMMUNOL RES2014 1 (2014).
29 Peng, G. et al., PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. MOL IMMUNOL45 963 (2008).
30 Kuai, W. et al., Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer. BIOMED RES INT2020 5294043 (2020).
31 Goltz, D., Gevensleben, H., Dietrich, J. & Dietrich, D., PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients. ONCOIMMUNOLOGY6 e1257454 (2017).
32 Chang, Y. et al., 494 PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer. J INVEST DERMATOL138 S84 (2018).
33 Liu, X. et al., PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma. Cancer Immunology, Immunotherapy68 2041 (2019).
34 Li, Z. et al., Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma. Oncotarget7 26168 (2016).
35 Wu, J. et al., Suppression of Furin by Interferon-γ and the Impact on Hepatitis B Virus Antigen Biosynthesis in Human Hepatocytes. The American Journal of Pathology181 19 (2012).
36 Jung, M. C. et al., Increased frequency of CD8+ CD45R0+ memory T lymphocytes in acute hepatitis B virus infection. J HEPATOL18 295 (1993).
37 Penna, A. et al., Long-lasting memory T cell responses following self-limited acute hepatitis B. The Journal of clinical investigation98 1185 (1996).
38 Zhang, Z. et al., Dynamic Programmed Death 1 Expression by Virus-Specific CD8 T Cells Correlates With the Outcome of Acute Hepatitis B. GASTROENTEROLOGY134 1938 (2008).